Evidence map›Paper›PMID 28465709›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2017

Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms.

Damiana Scuteri, Luigi Antonio Morrone, Laura Rombolà, Pina Rosa Avato, Anna Rita Bilia, Maria Tiziana Corasaniti, Shinobu Sakurada, Tsukasa Sakurada, Giacinto Bagetta

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04321889 (Randomized Double-blind Controlled Trial to Evaluate the Efficacy of Defurocumarinized Bergamot Loaded in a Nanotechnological System for the Release of Essential Oil in the Treatment of Agitation in Severe Dementia Patients.), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04321889 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Randomized Double-blind Controlled Trial to Evaluate the Efficacy of Defurocumarinized Bergamot Loaded in a Nanotechnological System for the Release of Essential Oil in the Treatment of Agitation in Severe Dementia Patients.

TypeinterventionalSponsorS.Anna Rehabilitation InstituteRan2020 to 2021Enrolled134ConditionsSevere Dementia, StrokeArmsdefurocumarinized bergamot loaded in a nanotechnological essential oil release system, Placebo
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Using an aromatherapy intervention withInternational journal of nursing sciences · 2025
    Article
  5. Article
  6. Article
  7. The Effect of Olfactory Inhalation on KPGA Golfers' Putting Performance, Postural Stability and Heart Rate.International journal of environmental research and public health · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Aromatherapy in Stroke Patients: Is it Time to Begin?Frontiers in behavioral neuroscience · 2021
    Review
  12. Article
  13. Plant Natural Compounds in the Treatment of Adrenocortical Tumors.International journal of endocrinology · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Multi-sensory potential of archives in dementia care.Archives and records (Abingdon, England) · 2020
    Article
  19. Neuroprotective Studies onFrontiers in pharmacology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Damiana ScuteriDepartment of Pharmacy, Health Science and Nutrition, University of Calabria, 87036 Rende, Italy.
Luigi Antonio MorroneDepartment of Pharmacy, Health Science and Nutrition, University of Calabria, 87036 Rende, Italy.
Laura RombolàDepartment of Pharmacy, Health Science and Nutrition, University of Calabria, 87036 Rende, Italy.
Pina Rosa AvatoDepartment of Pharmacy and Drug Science, University of Bari "Aldo Moro", 70125 Bari, Italy.
Anna Rita BiliaDepartment of Chemistry, University of Florence, Sesto Fiorentino, 50019 Florence, Italy.ORCID 0000-0001-8772-1895
Maria Tiziana CorasanitiDepartment of Health Sciences, University "Magna Græcia" of Catanzaro, 88100 Catanzaro, Italy.
Shinobu SakuradaFirst Department of Pharmacology, Daiichi College of Pharmaceutical Sciences, Fukuoka, Japan.
Tsukasa SakuradaDepartment of Physiology and Anatomy, Tohoku Pharmaceutical University, Sendai, Japan.
Giacinto BagettaDepartment of Pharmacy, Health Science and Nutrition, University of Calabria, 87036 Rende, Italy.ORCID 0000-0001-8540-6218
University of Calabria · ITDaiichi University of Pharmacy · JPMagna Graecia University · ITTohoku Medical and Pharmaceutical University · JPUniversity of Bari Aldo Moro · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of agitation and aggression, typical Behavioural and Psychological Symptoms of Dementia (BPSDs) of Alzheimer's Disease (AD), is one of the most complicated aspects of handling patients suffering from dementia. Currently, the management of these symptoms often associated with an increased pain perception, which notably reduces the patients' quality of life (QoL), relies on the employment of antipsychotic drugs. Unfortunately, the use of these pharmacological agents has some limits: in the long term, they do not result in being equally effective as in the first weeks of treatment and they present important side effects. Therefore, there is growing interest, supported by clinical evidence, in aromatherapy for the control of agitation, aggression, and psychotic symptoms. Some molecular mechanisms have been proposed to explain the behavioural effects of essential oils, as the whole phytocomplex or the single components, but important basic research effort is still needed. For this reason, rigorous preclinical studies are necessary in order to understand the pharmacological basis of aromatherapy in the treatment of BPSDs and to widen the cluster of effective essential oils in pharmacotherapeutic practice.

Identifiers

PMID28465709
PMCPMC5390566
OpenAlexW2602280041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.